Amylin pharmaceuticals News
Most Popular Amylin pharmaceuticals Story
Amgen, Amylin lobby against biogenerics
Fearing competition from generic biotech drugs, Amgen shelled out $2.4 million last quarter lobbying the federal government. Amylin Pharmaceuticals also spent $540K on the same issue. While a system... Read more...
Latest Headlines
- April 21, 2009
- April 1, 2009
- March 27, 2009
- December 5, 2008
- November 10, 2008
- July 29, 2008
- June 20, 2008
- March 4, 2008
- November 27, 2007
- January 31, 2007
- January 30, 2007
- January 29, 2007
- September 13, 2006
- July 31, 2006
- April 4, 2006
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
